These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20364308)

  • 21. Strong association between c-myb and oestrogen-receptor expression in human breast cancer.
    Guérin M; Sheng ZM; Andrieu N; Riou G
    Oncogene; 1990 Jan; 5(1):131-5. PubMed ID: 2181374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.
    Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J
    Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transactivation of cytosolic alanine aminotransferase gene promoter by p300 and c-Myb.
    Anemaet IG; González JD; Salgado MC; Giralt M; Fernández F; Baanante IV; Metón I
    J Mol Endocrinol; 2010 Sep; 45(3):119-32. PubMed ID: 20573775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer].
    Guerin M; Barrois M; Riou G
    C R Acad Sci III; 1988; 307(20):855-61. PubMed ID: 2907731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
    Tedesco D; Vesco C
    Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
    Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
    BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
    Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-myb mediates inflammatory reaction against oxidative stress in human breast cancer cell line, MCF-7.
    Bhattarai G; Lee YH; Lee NH; Yun JS; Hwang PH; Yi HK
    Cell Biochem Funct; 2011 Dec; 29(8):686-93. PubMed ID: 21953443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and regulation of c-Myb target genes in MCF-7 cells.
    Quintana AM; Liu F; O'Rourke JP; Ness SA
    BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
    Chen L; Xu S; Zeng X; Li J; Yin W; Chen Y; Shao Z; Jin W
    Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):1-7. PubMed ID: 20043041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.
    Tan-Wong SM; French JD; Proudfoot NJ; Brown MA
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5160-5. PubMed ID: 18375767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of BRCA1 expression by a metabolic switch.
    Di LJ; Fernandez AG; De Siervi A; Longo DL; Gardner K
    Nat Struct Mol Biol; 2010 Dec; 17(12):1406-13. PubMed ID: 21102443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells.
    Thadani NA; McNamee JP; Winn LM
    Pharmacol Res; 2006 Aug; 54(2):91-6. PubMed ID: 16616857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional autoregulation by BRCA1.
    De Siervi A; De Luca P; Byun JS; Di LJ; Fufa T; Haggerty CM; Vazquez E; Moiola C; Longo DL; Gardner K
    Cancer Res; 2010 Jan; 70(2):532-42. PubMed ID: 20068145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.